title: Pre- and post-natal treatment of hemophagocytic lymphohistiocytosis.
abstract: Hemophagocytic lymphohistiocytosis (HLH) is a rare autosomal recessive disorder of infancy and childhood that is invariably fatal if not treated. We report on the first patient to receive post-natal HSCT for HLH after receiving in utero chemotherapy for disease stabilization.
authors.affiliation: Division of Research Immunology, Childrens Hospital Los Angeles, California 90027, USA. ashah@chla.usc.edu
authors.forename: Ami J
authors.initials: AJ
authors.lastname: Shah
authors.forename: Neena
authors.initials: N
authors.lastname: Kapoor
authors.forename: Robert M
authors.initials: RM
authors.lastname: Cooper
authors.forename: Gay M
authors.initials: GM
authors.lastname: Crooks
authors.forename: Carl
authors.initials: C
authors.lastname: Lenarsky
authors.forename: Hisham
authors.initials: H
authors.lastname: Abdel-Azim
authors.forename: Shi Qi
authors.initials: SQ
authors.lastname: Wu
authors.forename: Kathy
authors.initials: K
authors.lastname: Wilson
authors.forename: Kenneth I
authors.initials: KI
authors.lastname: Weinberg
authors.forename: Robertson
authors.initials: R
authors.lastname: Parkman
authors.forename: Donald B
authors.initials: DB
authors.lastname: Kohn
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use; D003072:Cognition Disorders; D002658:Developmental Disabilities; D005260:Female; D046128:Fetal Therapies; D005333:Fetus; D005500:Follow-Up Studies; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D007231:Infant, Newborn; D051359:Lymphohistiocytosis, Hemophagocytic / Q000175:diagnosis* / Q000503:physiopathology / Q000628:therapy*; D011247:Pregnancy
chemical_list: D000970:Antineoplastic Agents